A Postmarket Clinical Trial for EXCROSSAL Stent in CAD Patients With 3-month DAPT or 12-month DAPT
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 2700 participants.
Also called NCT03716011
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 2,700 participants
- Sponsor
- Registry
-
NCT03716011
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT03716011. Allocation not applicable; no masking; primary purpose treatment. Start 2018-12-20 (anticipated); primary completion 2021-12-20 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Postmarket Clinical Trial for EXCROSSAL Stent in CAD Patients With 3-month DAPT or 12-month DAPT
- Condition
- Coronary Artery Disease
- Intervention (Device)
- EXCROSSAL
- Lead sponsor
- JW Medical Systems Ltd
Record details
- Record id
cardio:ct-nct03716011- Content hash
50fd636a5fa96c1f4f88b708b7e297b55c0eb9dc18033cc4b8610780bcea3be7